Panacea Biotec Company Description
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally.
The company operates through Vaccines and Pharmaceutical Formulations & Nutrition segments. Its product portfolio includes prescription products in various therapeutic areas, such as diabetes, gastro-intestinal care, nephrology, oncology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, and Mpox, etc. The company also offers health supplement products; and nutrition products under the ChilRun full, ChilRun 7+, and ChillRun No Sucrose brands.
In addition, it engages in the real estate business. It exports its products to approximately 50 countries.
It has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine.
Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Contact Details
Address: B-1 Extn./A-27 New Delhi, Punjab 110044 India | |
| Phone | 91 11 4167 9000 |
| Website | panaceabiotec.com |
Stock Details
| Ticker Symbol | PANACEABIO |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE922B01023 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Rajesh Jain Ph.D. | Chairman of the Board and MD |
| Sandeep Jain | Joint MD and Executive Director |
| Vinod Goel | Group Chief Financial Officer and Head of Legal and Corporate Governance |
| Dr. Khalid Al Syed | Chief Scientific Officer |
| Rajneesh Chatrath | Vice President of Corporate Quality Assurance |
| Ranandu Bhattacharya | Vice President - Panacea Vaccines SBU |
| Dr. Amulya Kumar Panda | Associate Director |
